Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Blanck

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Archivum Immunologiae Et Therapiae Experimentalis|July 9, 2002
Components of the IFN-gamma signaling pathway in tumorigenesisGeorge Blanck
Teaching and Learning in Medicine|October 16, 2014
The rise of the biomedical sciences master's program at U.S. medical collegesGeorge Blanck
Human Vaccines & Immunotherapeutics|December 19, 2013
The future of cancer research: prevention, screening, vaccines, and tumor-specific drug combosGeorge Blanck
Cancer Immunology, Immunotherapy : CII|September 19, 2003
Mutations and regulatory anomalies effecting tumor cell immune functionsGeorge Blanck
Molecular Immunology|December 21, 2002
The IRF-2 DNA binding domain facilitates the activation of the class II transactivator (CIITA) type IV promoter by IRF-1Hongkang Xi, George Blanck
Human Vaccines & Immunotherapeutics|July 31, 2015
Flat cells come full sphere: Are mutant cytoskeletal-related proteins oncoprotein-monsters or useful immunogens?Michele L Parry, George Blanck
Physiological Reports|January 1, 2017
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlasJohn M Yavorski, George Blanck
Biological & Pharmaceutical Bulletin|March 3, 2009
Rescue of major histocompatibility-DR surface expression in retinoblastoma-defective, non-small cell lung carcinoma cells by the MS-275 histone deacetylase inhibitorMelissa Ihla Niesen, George Blanck
Biochimica Et Biophysica Acta|December 3, 2014
Signal persistence and amplification in cancer development and possible, related opportunities for novel therapiesShea A Ford, George Blanck
Cell and Tissue Research|August 22, 2015
Immunoscoring by correlating MHC class II and TCR expression: high level immune functions represented by the KIRP dataset of TCGAShanitra N Butler, George Blanck
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Archivum Immunologiae Et Therapiae Experimentalis|July 9, 2002
Components of the IFN-gamma signaling pathway in tumorigenesisGeorge Blanck
Teaching and Learning in Medicine|October 16, 2014
The rise of the biomedical sciences master's program at U.S. medical collegesGeorge Blanck
Human Vaccines & Immunotherapeutics|December 19, 2013
The future of cancer research: prevention, screening, vaccines, and tumor-specific drug combosGeorge Blanck
Cancer Immunology, Immunotherapy : CII|September 19, 2003
Mutations and regulatory anomalies effecting tumor cell immune functionsGeorge Blanck
Molecular Immunology|December 21, 2002
The IRF-2 DNA binding domain facilitates the activation of the class II transactivator (CIITA) type IV promoter by IRF-1Hongkang Xi, George Blanck
Human Vaccines & Immunotherapeutics|July 31, 2015
Flat cells come full sphere: Are mutant cytoskeletal-related proteins oncoprotein-monsters or useful immunogens?Michele L Parry, George Blanck
Physiological Reports|January 1, 2017
Smoking correlates with increased cytoskeletal protein-related coding region mutations in the lung and head and neck datasets of the cancer genome atlasJohn M Yavorski, George Blanck
Biological & Pharmaceutical Bulletin|March 3, 2009
Rescue of major histocompatibility-DR surface expression in retinoblastoma-defective, non-small cell lung carcinoma cells by the MS-275 histone deacetylase inhibitorMelissa Ihla Niesen, George Blanck
Biochimica Et Biophysica Acta|December 3, 2014
Signal persistence and amplification in cancer development and possible, related opportunities for novel therapiesShea A Ford, George Blanck
Cell and Tissue Research|August 22, 2015
Immunoscoring by correlating MHC class II and TCR expression: high level immune functions represented by the KIRP dataset of TCGAShanitra N Butler, George Blanck
Pageof 15